Work

Sat0396 Improvement in the Signs and Symptoms of Psoriatic Arthritis With Ixekizumab Compared to Placebo in Patient Subgroups Defined by Baseline Disease Characteristics

Year: 2019

Type: article

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2019-eular.1620

Authors: Hans-Peter Tony, Eva Galindez, Aubrey Trevelin Sprabery, Amanda M. Gellett, Chen-Yen Lin, So Young Park, Clinton C. Bertram, Alexis Ogdie

Institutions: Universitätsklinikum Würzburg, Hospital de Basurto, Eli Lilly (United States), University of Pennsylvania Health System

Language: English

Topic: Spondyloarthritis Studies and Treatments

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Bristol-Myers Squibb, Pfizer

OpenAlex ID: W2950855053

FWCI: 0.378

Cites:

Cited by: 2

Related to: 10